Audited Results of Suven Life Sciences Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	6.66	11.69	13.54	11.84	13.48
Manufacturing Expenses	0.30	0.26	0	0	0
Personnel Expenses	20.82	16.53	15.77	17.46	15.29
Selling Expenses	0	0	0	0	0
Administrative Expenses	36.43	25.12	25.51	31.02	28.74
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	58.59	42.63	41.28	48.49	44.03
Operating Profit	-51.94	-30.94	-27.74	-36.64	-30.55
Other Recurring Income	10.73	21.13	8.45	5.32	7.75
Adjusted PBDIT	-41.21	-9.81	-19.29	-31.33	-22.79
Financial Expenses	0.05	0.16	0.29	0.53	0.82
Depreciation	5.82	6.50	6.54	4.39	4.35
Other Write offs	0	0	0	0	0
Adjusted PBT	-47.08	-16.47	-26.13	-36.25	-27.95
Tax Charges	0	-1	0	0	-5.32
Adjusted PAT	-47.08	-15.46	-26.13	-36.25	-22.63
Non Recurring Items	-0.06	7.40	6.19	-0.15	-0.31
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	-47.08	-8.01	-20.13	-36.25	-22.63
Equity Dividend	0	0	0	0	0
Preference Dividend	0	0	0	0	0
Retained Earnings	86.29	133.43	141.49	161.43	197.83

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article